Cigna Group Partners with OpenAI to Enhance Personalized Cancer Care with AI
The Cigna Group has announced a new partnership with OpenAI to integrate artificial intelligence into its care management processes, specifically targeting personalized care for individuals with complex conditions, initially focusing on oncology. This collaboration aims to combine OpenAI's advanced reasoning capabilities with Cigna's clinical expertise and care management insights. The initiative will leverage Cigna's Accredo Specialty Pharmacy to help clinical care teams anticipate patient needs, provide early personalized interventions, and coordinate care across various medical teams. The goal is to streamline care, identify emerging needs sooner, and offer more tailored support throughout a patient's treatment journey. For instance, the AI system could flag common side effects for a newly diagnosed breast cancer patient and automate outreach to assess and mitigate these issues, integrating this data into the patient's record for further personalization. Cigna emphasizes that AI-generated information wi...
